Chief Medical Officer
Tue, Jul 14, 2026
Jul 14
16,250 shares @ $5.13
Decreased holdings by -100.00%
9th largest trade (out of 45)
Planned (10b5-1)
“The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 2, 2026, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on May 15, 2026”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 44% above 200-day moving average
Small Cap stock — insider trades carry more weight